Caribou Biosciences, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $20.3M | $20.3M | $22.0K | $343.0K |
| Jun 2021 | $-16.5M | $-17.0M | $484.0K | — |
| Sep 2021 | $-15.0M | $-15.9M | $930.0K | — |
| Mar 2022 | $-21.7M | $-22.4M | $723.0K | $3.0M |
| Jun 2022 | $-21.9M | $-24.5M | $2.6M | — |
| Sep 2022 | $-22.4M | $-23.7M | $1.4M | — |
| Mar 2023 | $-27.9M | $-30.0M | $2.0M | $3.1M |
| Jun 2023 | $-15.2M | $-17.7M | $2.6M | — |
| Sep 2023 | $-28.8M | $-33.5M | $4.8M | — |
| Mar 2024 | $-37.2M | $-38.7M | $1.4M | $4.0M |
| Jun 2024 | $-32.9M | $-35.1M | $2.2M | — |
| Sep 2024 | $-32.7M | $-33.3M | $673.0K | — |
| Mar 2025 | $-36.7M | $-37.8M | $1.0M | $3.9M |
| Jun 2025 | $-28.3M | $-28.7M | $418.0K | — |
| Sep 2025 | $-25.2M | $-25.3M | $115.0K | — |
| Mar 2026 | $-27.0M | $-27.1M | $72.0K | $2.4M |
| Jun 2026 | $-22.8M | $-22.8M | $1.0K | — |